Oppenheimer Has Lowered Expectations for Jasper Therapeutics (NASDAQ:JSPR) Stock Price
Jasper Therapeutics (NASDAQ:JSPR – Free Report) had its target price decreased by Oppenheimer from $80.00 to $65.00 in a report published on Thursday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the stock. JSPR has been the topic of several other research reports. HC Wainwright restated a “buy” rating and issued a $40.00 target […]
Jasper Therapeutics (NASDAQ:JSPR – Free Report) had its target price decreased by Oppenheimer from $80.00 to $65.00 in a report published on Thursday morning,Benzinga reports. Oppenheimer currently has an outperform rating on the stock. JSPR has been the topic of several other research reports. HC Wainwright restated a “buy” rating and issued a $40.00 target […]
